pharmaphorum

NOVEMBER 30, 2020

In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.

Big Data 52

Big Data Life Science Development Drugs 52

ACRP blog

APRIL 5, 2023

AI is increasingly important in drug discovery and development as well as clinical trials, operations, pharmacovigilance, and many other areas.” This will also allow companies to utilize advanced computational models to find better treatments more quickly while also reducing costs associated with drug development.

Clinical Trials 52

Clinical Trials Clinical Trials Big Data Life Science 52

XTalks

JULY 24, 2024

XTALKS WEBINAR: Digital Health Tools That Will Transform Cancer Treatment Live and On-Demand: Thursday, August 22, 2024, at 1pm EDT (10am PDT) Register for this webinar today to learn how pharmaceutical and life science technology companies are collaborating to harness digital health tools in oncology care delivery. Nanostics Inc.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

pharmaphorum

FEBRUARY 1, 2022

David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. His research focuses on the development of big data machine learning for tracking the health of complex systems. Mark holds a PhD in biomedicine, and an MSc in biostatistics.

Clinical Trials 99

Clinical Trials Clinical Trials Trials Engineer 99

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

Pharma Marketing Network

AUGUST 18, 2021

Recent shifts in rep access, HCP media preferences and the emergence of new data-driven platforms have forced pharmaceutical and life science organizations to accelerate their digital transformation. Marketing Agility – the Path to Digital Engagement & Innovation.

Marketing 98

Marketing Big Data Life Science Branding 98

XTalks

OCTOBER 18, 2022

Related: Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. HFX iQ takes direct input from each patient on their pain and quality of life measures to get smarter over time and recommend program changes.”.

FDA Approval 83

FDA Approval Big Data Life Science Clinical Trials 83

Pharma Marketing Network

SEPTEMBER 22, 2021

Recent shifts in rep access, HCP media preferences and the emergence of new data-driven platforms have forced pharmaceutical and life science organizations to accelerate their digital transformation. Marketing Agility – the Path to Digital Engagement & Innovation.

Big Data 52

Big Data Marketing Life Science Licensing 52

Cloudbyz

SEPTEMBER 8, 2024

The Pressing Need for Transformation However, this increase in investment has been associated with a decline in R&D productivity in biopharma: in 2020, the mean development cost for a novel drug stood at $2.6 billion recorded in 2010, while return on that investment in drug development crashed from 10.1% in 2010 to a mere 1.8%

Clinical Trials 40

Clinical Trials Clinical Trials Trials Production 40

pharmaphorum

FEBRUARY 11, 2022

Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.

Life Science 101

Life Science Engineer Development Big Data 101

Pharma Marketing Network

SEPTEMBER 22, 2021

Recent shifts in rep access, HCP media preferences and the emergence of new data-driven platforms have forced pharmaceutical and life science organizations to accelerate their digital transformation. Marketing Agility – the Path to Digital Engagement & Innovation.

Big Data 40

Big Data Marketing Life Science Licensing 40

XTalks

MAY 9, 2024

We also invented four proprietary antibody technologies, including our DuoBody® bispecific technology which is the backbone of four FDA-approved bispecifics and over ten in development. What factors do you attribute to the company’s success in the discovery and development of differentiated antibody therapeutics?

Antibody 52

Antibody Clinical Trials Clinical Trials Medicine 52

pharmaphorum

OCTOBER 16, 2020

With large datasets crucial to gaining an understanding of rare diseases and opening the door to drug development, digital technology is proving transformative. Many are working to develop registries (some using wearable technologies or apps) and natural history studies, which means that ever-greater volumes of data are being produced.

Trials 101

Trials Clinical Trials Clinical Trials Life Science 101

XTalks

APRIL 5, 2021

Since the conclusion of the project in 2003, bioinformatics tools have been used to identify genes and elucidate their function with the aim of developing gene-based strategies for disease prevention, diagnosis and treatment. This job furthers the field of biomedical research and supports drug development.

Bioinformatics 52

Bioinformatics Engineer Scientist Genome 52

pharmaphorum

APRIL 8, 2022

Dennis Kadioglu is the deputy head of both the Medical Informatics Group (MIG) and the Data Integration Center (DIC) at the University Hospital Frankfurt in Frankfurt am Main. Josef Schepers is deputy director of the Core Unit E-Health and Interoperability within Berlin Institute of Health at Charité – Universitätsmedizin Berlin.

Genome 60

Genome Genomics Research Big Data 60

The Pharma Data

JULY 12, 2021

The study findings could measurably change how researchers sift through big data to find meaningful information with significant benefit to patients, the pharmaceutical industry and the nation’s health care systems. have access to unlimited amounts of ‘big data’ and better tools than ever to analyze such data. .”

Drugs 52

Drugs Gene Expression Big Data Gene 52

pharmaphorum

JULY 4, 2022

Alongside technical issues, compliance with data protection regulations, pseudo- and anonymisation of data, ethical and legal issues, patient’s consent, and local governmental policies pose additional elements that must be addressed and might differ between the countries, impacting international data sharing.

Genome 105

Genome Genomics Research Medicine 105

pharmaphorum

MAY 30, 2022

The company developed the first FDA-authorised at-home VR pain treatment, RelieVRx, indicated as an adjunctive treatment for chronic lower back pain. He oversees operations, including business development, sales and marketing, and people. Distinct offerings. AppliedVR creates VR-based treatments aimed at relieving chronic pain.

Clinical Trials 92

Clinical Trials Clinical Trials Trials Big Data 92

pharmaphorum

SEPTEMBER 18, 2020

The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin. “AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. Zeneca Group plc. MedImmune acquisition.

Pharma Companies 116

Pharma Companies Sales Vaccine Vaccination 116

XTalks

AUGUST 2, 2023

is a global pharmaceutical company, working across both developed and emerging markets. They are committed to capitalizing on growth opportunities primarily through the advancement of their own product pipeline and constantly improving their existing products, as well as through business development activities. Pfizer Inc.

Sales 85

Sales Manufacturing FDA Approval Life Science 85

pharmaphorum

MARCH 16, 2021

The use of real-world evidence is proving beneficial for pharma and medical devices companies across the lifecycle of development from R&D to re-purposing. There are a good number of use cases as to why pretty much every big life science company is choosing us these days,” says Medrano. AI use in the pandemic.

Doctor 115

Doctor Doctors Life Science Clinical Research 115

Pharmaceutical Technology

JUNE 20, 2023

The current tech landscape is rapidly evolving, with advancements in areas such as big data and conversational platforms. Most of us have heard of ChatGPT and AI but where and how do they fit into the life sciences ecosystem? Neural networks learn to “translate” from language A to language B.

Life Science 130

Life Science Clinical Trials Clinical Trials Regulation 130

pharmaphorum

FEBRUARY 17, 2022

Identified as the “VB variant,” the virus has proved to be highly virulent and to speed up the progression of a patient developing AIDS faster. Led by researchers from the University of Oxford ‘s Big Data Institute, the study underscores the significance of analysing viruses continually over time.

Genome 97

Genome Genomics Genetics Genotype 97

The Pharma Data

JANUARY 17, 2021

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond. .

Life Science 52

Life Science Engineer Big Data Scientist 52

Pharmaceutical Technology

JANUARY 11, 2023

Services such as Personal Health Records and diagnostic apps collect, store and analyse patient data, which assists healthcare practitioners with diagnosis as well as enabling them to create tailored treatment plans based on the needs of the patient. Hamilton: Canada’s emerging leader in life sciences research and commercialization.

Life Science 130

Life Science Engineer Doctors Doctor 130